Quest Diagnostics (DGX) Change in Cash (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Change in Cash data on file, last reported at -$27.0 million in Q1 2026.

• Quarterly Change in Cash rose 92.52% year-over-year to -$27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $205.0 million (up 171.68% YoY) and the FY2025 annual result came in at -$129.0 million, up 5.84% from the prior year.
• Change in Cash eased to -$27.0 million in Q1 2026 per DGX's latest filing, from -$12.0 million in the prior quarter.
• The five-year high for Change in Cash was $543.0 million in Q4 2023, with the low at -$385.0 million in Q4 2022.
• Average Change in Cash over 5 years is -$28.2 million, with a median of -$49.0 million recorded in 2023.
• Year-over-year, Change in Cash sank 322.22% in 2022 and surged 2800.0% in 2024.
• Quest Diagnostics' Change in Cash stood at -$385.0 million in 2022, then surged by 241.04% to $543.0 million in 2023, then plunged by 139.59% to -$215.0 million in 2024, then jumped by 94.42% to -$12.0 million in 2025, then plunged by 125.0% to -$27.0 million in 2026.
• Business Quant data shows DGX's Change in Cash at -$27.0 million in Q1 2026, -$12.0 million in Q4 2025, and $113.0 million in Q3 2025.